Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
Eli Lilly, Tan France launch Zepbound ‘Changing the Thread’
New innovative campaign weaves science and storytelling to help reframe obesity as a chronic disease INDIANAPOLIS, Nov. 10,…
Cardiology has ignored women. AHA’s leader thinks AI can help
NEW ORLEANS — Stacey Rosen is a cardiologist who has been coming to American Heart Association meetings for…
UnitedHealthcare drops remote monitoring coverage
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Amgen’s Repatha cholesterol shot slashed heart attack risk by 36%
Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
TrumpRx to offer discount weight loss drugs after Lilly, Novo deals
WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…
Aerobic exercises the best for knee osteoarthritis
For patients with knee osteoarthritis, aerobic activities such as walking, cycling or swimming are likely to be the…
University Health opens new center to expand care in San Antonio’s East Side
SAN ANTONIO — University Health has opened the Wheatley health center on San Antonio’s East Side, marking the…
Apple Watch hypertension app: Experts see benefit despite limitations
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
‘Heart disease and diabetes contributing heavily’: Chronic illness deaths increased in India, finds Lancet study
India has emerged as one of the countries where the chances of dying from a chronic disease such…